Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.

Dravet syndrome is a rare and severe form of epilepsy that typically manifests in infancy and is characterized by prolonged, ...

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

On a mission to overcome the dosing challenges posed by radiotherapy, French nanotherapy company Nanobiotix is developing a ...

As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...

The promise of AI in biotech and in oncology is vast. Lately, AI utilization in the health industry has seen signs of a market correction to the point where we wondered whether we were in an AI bubble ...

The biopharma industry is always in need of talented minds to take promising pipelines to the clinic and beyond. A good biotech entrepreneur is able to cope with change and failure and has proven ...

Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer.

Discover advances in epilepsy treatments, innovative solutions for seizure freedom, and challenges in integrating new ...